Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
82,180 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Sep 30, 2026 | Regence BCBS | Interspinous and Interlaminar Stabilization and Distraction Devices (Spacers)PayerPolicy · REGENCE-SUR155 | Metadata changed |
|---|
| Sep 30, 2026 | Regence BCBS | Implantable Peripheral Nerve Stimulation and Peripheral Subcutaneous Field StimulationPayerPolicy · REGENCE-SUR205 | Metadata changed |
|---|
| Sep 30, 2026 | Regence BCBS | Hyperoxemic Reperfusion ThearpyPayerPolicy · REGENCE-MED173 | Metadata changed |
|---|
| Sep 30, 2026 | Regence BCBS | Genotyping for 9p21 Single Nucleotide Variants to Predict Risk of Cardiovascular Disease or AneurysmPayerPolicy · REGENCE-GT62 | Metadata changed |
|---|
| Sep 30, 2026 | Regence BCBS | Genetic Testing for PTEN Hamartoma Tumor SyndromePayerPolicy · REGENCE-GT63 | Metadata changed |
|---|
| Sep 30, 2026 | Regence BCBS | Genetic Testing for Alpha-1 Antitrypsin DeficiencyPayerPolicy · REGENCE-GT61 | Metadata changed |
|---|
| Sep 30, 2026 | Regence BCBS | Focal Laser Ablation of Prostate CancerPayerPolicy · REGENCE-SUR222 | Metadata changed |
|---|
| Sep 30, 2026 | Regence BCBS | Femoroacetabular Impingement SurgeryPayerPolicy · REGENCE-SUR160 | Metadata changed |
|---|
| Sep 30, 2026 | Regence BCBS | Femoroacetabular Impingement SurgeryPayerPolicy · REGENCE-SUR160a | New policy |
|---|
| Sep 30, 2026 | Regence BCBS | Eye Tracking to Detect Autism Spectrum Disorder in ChildrenPayerPolicy · REGENCE-BH38 | New policy |
|---|
| Sep 30, 2026 | Regence BCBS | Dynamic Stabilization of the SpinePayerPolicy · REGENCE-SUR143 | Metadata changed |
|---|
| Sep 30, 2026 | Regence BCBS | Cosmetic and Reconstructive ProceduresPayerPolicy · REGENCE-SUR12 | Metadata changed |
|---|
| Sep 30, 2026 | Regence BCBS | Cooling Devices Used in the Home SettingPayerPolicy · REGENCE-DME07 | Metadata changed |
|---|
| Sep 30, 2026 | Regence BCBS | Cochlear ImplantPayerPolicy · REGENCE-SUR08 | Metadata changed |
|---|
| Sep 30, 2026 | Regence BCBS | Cochlear ImplantPayerPolicy · REGENCE-SUR08a | New policy |
|---|
| Sep 30, 2026 | Regence BCBS | Chemical PeelsPayerPolicy · REGENCE-SUR12.50 | Metadata changed |
|---|
| Sep 30, 2026 | Regence BCBS | Bone Lengthening (Distraction Osteogenesis)PayerPolicy · REGENCE-SUR29 | New policy |
|---|
| Sep 30, 2026 | Regence BCBS | Artificial Intervertebral DiscPayerPolicy · REGENCE-SUR127 | Metadata changed |
|---|
| Sep 30, 2026 | Regence BCBS | Artificial Intervertebral DiscPayerPolicy · REGENCE-SUR127a | New policy |
|---|
| Sep 30, 2026 | Regence BCBS | Applied Behavior Analysis for the Treatment of Autism Spectrum DisordersPayerPolicy · REGENCE-BH18a | New policy |
|---|
| Sep 30, 2026 | Capital Blue Cross | Molecular Testing for Germline Variants Associated with Ovarian Cancer (BRIP1, RAD51C, RAD51D, NBN) (Retired 7/1/2026)PayerPolicy · CAPBLUE-MP-2.377 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Germline Genetic Testing for Gene Variants Associate with Breast Cancer in Individuals at High Breast Cancer Risk (CHEK2, ATM, and BARD1) (Retired 7/1/2026)PayerPolicy · CAPBLUE-MP-2.279 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Whole Exome and Whole Genome Sequencing for Diagnosis of Genetic Disorders (Retired 7/1/2026)PayerPolicy · CAPBLUE-MP-2.324 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Vertebral Axial DecompressionPayerPolicy · CAPBLUE-MP-2.065 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Use of Common Genetic Variants (Single Nucleotide Polymorphisms) to Predict Risk of Non-Familial Breast Cancer (Retired 7/1/2026)PayerPolicy · CAPBLUE-MP-2.249 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Treatment of Varicose Veins - Venous InsufficiencyPayerPolicy · CAPBLUE-MP-1.061 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Transvaginal and Transurethral Radiofrequency Tissue Remodeling for Urinary Stress Incontinence (Retired 9/1/2026)PayerPolicy · CAPBLUE-MP-4.034 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Transmyocardial Revascularization (Retired 7/1/2026)PayerPolicy · CAPBLUE-MP-1.057 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Surgical Ventricular RestorationPayerPolicy · CAPBLUE-MP-1.082 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Surgical Treatment of Sleep Apnea and SnoringPayerPolicy · CAPBLUE-MP-1.128 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Subcutaneous Hormone Pellet ImplantsPayerPolicy · CAPBLUE-MP-2.345 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Stem Cell Therapy for Peripheral Arterial DiseasePayerPolicy · CAPBLUE-MP-2.089 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Somatic Genetic Testing to Select Individuals with Melanoma or Glioma for Targeted Therapy or Immunotherapy (Retired 7/1/2026)PayerPolicy · CAPBLUE-MP-2.364 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Somatic Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment of Metastatic Colorectal Cancer (KRAS, NRAS, BRAF, NTRK, and HER2) (Retired 7/1/2026)PayerPolicy · CAPBLUE-MP-2.316 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Somatic Biomarker Testing For Immune Checkpoint Inhibitor Therapy (MSIMMR, PD-L1, TMB) (Retired 7/1/2026)PayerPolicy · CAPBLUE-MP-2.388 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Somatic Biomarker Testing (Including Liquid Biopsy) for Targeted Therapy in Non-Small Cell Lung (Retired 7/1/2026)PayerPolicy · CAPBLUE-MP-2.241 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Serum Biomarkers for Human Epididymis Protein 4 (HE4) (Retired 7/1/2026)PayerPolicy · CAPBLUE-MP-2.269 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Serum Antibody Markers for Diagnosing Inflammatory Bowel Disease (Retired 7/1/2026)PayerPolicy · CAPBLUE-MP-2.222 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Semi-Implantable and Fully Implantable Middle Ear Hearing AidPayerPolicy · CAPBLUE-MP-1.130 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Rhinomanometry and Acoustic/Optical RhinometryPayerPolicy · CAPBLUE-MP-2.088 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Proteomic Testing for Targeted Therapy in Non-Small-Cell Lung Cancer (Retired 7/1/2026)PayerPolicy · CAPBLUE-MP-2.337 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Proteogenomic Testing for Patients With Cancer (Retired 7/1/2026)PayerPolicy · CAPBLUE-MP-2.343 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Preimplantation Genetic Testing (Retired 7/1/2026)PayerPolicy · CAPBLUE-MP-7.009 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Polysomnography for Non-Respiratory Sleep DisordersPayerPolicy · CAPBLUE-MP-2.335 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Pharmacogenomic and Metabolite Markers for Patients Treated with Thiopurines (Retired 7/1/2026)PayerPolicy · CAPBLUE-MP-2.218 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Percutaneous Electrical Nerve Stimulation (PENs) and Percutaneous Neuromodulation Therapy (PNT)PayerPolicy · CAPBLUE-MP-6.050 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Orthognathic Surgery (Retired 9/1/2026)PayerPolicy · CAPBLUE-MP-1.101 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Open and Thoracoscopic Approaches to Treat Atrial Fibrillation and Atrial Flutter (Maze and Related Procedures) (Retired 7/1/2026)PayerPolicy · CAPBLUE-MP-2.083 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Oncological Applications of Photodynamic Therapy including Barrett's EsophagusPayerPolicy · CAPBLUE-MP-4.019 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Occipital Nerve StimulationPayerPolicy · CAPBLUE-MP-2.372 | Metadata changed |
|---|